C1-2017-17569. Identifying Trading Partners Under the Drug Supply Chain Security Act; Draft Guidance for Industry; Availability
-
Start Preamble
Correction
Notice document 2017-17569, appearing on pages 39589 through 39590, in the issue of Monday, August 21, 2017, was published in error. It should be removed.
End Preamble[FR Doc. C1-2017-17569 Filed 8-22-17; 8:45 am]
BILLING CODE 1301-00-D
Document Information
- Published:
- 08/23/2017
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Document Number:
- C1-2017-17569
- Pages:
- 40011-40011 (1 pages)
- Docket Numbers:
- Docket No. FDA-2017-D-1956
- PDF File:
- c1-2017-17569.pdf
- Supporting Documents:
- » Request for Extension from Healthcare Distribution Alliance (HDA)
- » Identifying Trading Partners Under the Drug Supply Chain Security Act; Revised Draft Guidance for Industry; Availability
- » Identifying Trading Partners Under the Drug Supply Chain Security Act; Revised Draft Guidance for Industry; Availability
- » Identifying Trading Partners Under the Drug Supply Chain Security Act Guidance for Industry
- » Identifying Trading Partners Under the Drug Supply Chain Security Act; Draft Guidance for Industry; Availability
- » Identifying Trading Partners Under the Drug Supply Chain Security Act; Draft Guidance for Industry; Availability
- » Guidance for Identifying Trading Partners Under the Drug Supply Chain Security Act
- » Identifying Trading Partners Under the Drug Supply Chain Security Act; Draft Guidance for Industry; Availability